Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia

Affiliations

• ¹ Departments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
• ² Biostatistics, University of Michigan, Ann Arbor, MI, USA.
• ³ Pathology, University of Michigan, Ann Arbor, MI, USA.
• ⁴ Statistics, University of Michigan, Ann Arbor, MI, USA.
• ⁵ Sanford Burham Prebys Medical Discovery Institute, San Diego, CA, USA.
• ⁶ Departments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA. smalek@med.umich.edu.